These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9684757)

  • 21. Pathogenesis of thrombosis in essential thrombocythemia and polycythemia vera: the role of neutrophils.
    Falanga A; Marchetti M; Barbui T; Smith CW
    Semin Hematol; 2005 Oct; 42(4):239-47. PubMed ID: 16210037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
    Kunitada S; FitzGerald GA; Fitzgerald DJ
    Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhancing effect of platelets on staphylokinase-mediated clot lysis and plasminogen activation.
    Suehiro A; Tsujioka H; Yoshimoto H; Ueda M; Higasa S; Kakishita E
    Thromb Res; 1995 Oct; 80(2):135-42. PubMed ID: 8588190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.
    Braaten JV; Handt S; Jerome WG; Kirkpatrick J; Lewis JC; Hantgan RR
    Blood; 1993 Mar; 81(5):1290-9. PubMed ID: 8443390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Platelets retain high levels of active plasminogen activator inhibitor 1.
    Brogren H; Wallmark K; Deinum J; Karlsson L; Jern S
    PLoS One; 2011; 6(11):e26762. PubMed ID: 22069469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation.
    Presseizen K; Friedman Z; Shapiro H; Radnay J; Ellis MH
    Clin Appl Thromb Hemost; 2002 Jan; 8(1):33-9. PubMed ID: 11991237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uncoupling fibrin from integrin receptors hastens fibrinolysis at the platelet-fibrin interface.
    Braaten JV; Jerome WG; Hantgan RR
    Blood; 1994 Feb; 83(4):982-93. PubMed ID: 8111066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelets inhibit fibrinolysis in vitro by both plasminogen activator inhibitor-1-dependent and -independent mechanisms.
    Fay WP; Eitzman DT; Shapiro AD; Madison EL; Ginsburg D
    Blood; 1994 Jan; 83(2):351-6. PubMed ID: 8286735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera.
    Rottenstreich A; Kleinstern G; Krichevsky S; Varon D; Lavie D; Kalish Y
    Eur J Intern Med; 2017 Jun; 41():49-54. PubMed ID: 27919526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target hematologic values in the management of essential thrombocythemia and polycythemia vera.
    Hernández-Boluda JC; Gómez M
    Eur J Haematol; 2015 Jan; 94(1):4-11. PubMed ID: 24814134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased circulating procoagulant activity and thrombin generation in patients with myeloproliferative neoplasms.
    Duchemin J; Ugo V; Ianotto JC; Lecucq L; Mercier B; Abgrall JF
    Thromb Res; 2010 Sep; 126(3):238-42. PubMed ID: 20656333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia.
    Musolino C; Allegra A; Saija A; Alonci A; Russo S; Spatari G; Penna G; Gerace D; Cristani M; David A; Saitta S; Gangemi S
    Clin Biochem; 2012 Nov; 45(16-17):1439-43. PubMed ID: 22850610
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-bound prekallikrein promotes pro-urokinase-induced clot lysis: a mechanism for targeting the factor XII dependent intrinsic pathway of fibrinolysis.
    Loza JP; Gurewich V; Johnstone M; Pannell R
    Thromb Haemost; 1994 Mar; 71(3):347-52. PubMed ID: 8029800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of residual platelets in plasma on plasminogen activator inhibitor-1 and plasminogen activator inhibitor-1-related assays.
    Pieters M; Barnard SA; Loots DT; Rijken DC
    PLoS One; 2017; 12(2):e0171271. PubMed ID: 28158230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation.
    Drabik L; Wołkow P; Undas A
    Thromb Res; 2015 Aug; 136(2):408-14. PubMed ID: 26048399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.